Apiam Animal Health Limited (ASX:AHX) is pleased to announce that it has successfully completed the fully-underwritten retail component of its pro rata 1 for 4.8 accelerated non-renounceable entitlement offer.
Apiam Animal Health Limited (ASX:AHX) MD Dr. Chris Richards speaks with Tim Mckinnon about the company's growth target of $300 Million by the end of 2024.
Nanollose Limited (ASX:NC6) (FRA:N0L) a leading bio-materials company focused on commercialising scalable technology to create fibres and fabrics with minimal environmental impact, is pleased to unveil its world-first garment made from 100% Tree-Free and Forest-Friendly NullarborTM lyocell fibre.
Apiam Animal Health Limited (ASX:AHX) would like to advise that the Company has today despatched its Retail Offer Document in respect of the 1 for 4.8 pro-rata non-renounceable entitlement offer announced on 26 May 2022.
Nanollose Limited (ASX:NC6) (FRA:N0L) announces the following additional information in respect of the binding memorandum of understanding entered into on 26 May 2022 with one of the world's largest fashion retailers, Industria de Diseno Textil, S.A.
Apiam Animal Health Limited (ASX:AHX) refers to its announcement of 19 May 2022 and confirms that it has completed the acquisition of the assets of Romsey Veterinary Service, effective 1 June 2022.
Nanollose Limited (ASX:NC6) Executive Chairman Dr. Wayne Best is interviewed by ABN Newswire on the recent news regarding global partnerships with leading fashion brands to use eco-friendly fibre in new products.
